VivoSim Labs (VIVS) Total Debt (2011 - 2024)

VivoSim Labs (VIVS) posted Total Debt of $353000.0 for Q4 2024, up 4312.5% on a QoQ basis from $8000.0 in Q4 2016.

Analysis

VivoSim Labs (VIVS) Total Debt (2011 - 2024) Analysis & Trends

VivoSim Labs has reported Total Debt for 7 years, with the latest figure at $353000.0 in Q4 2024.

On a quarterly basis, Total Debt changed N/A year-over-year to $353000.0 in Q4 2024; TTM through Dec 2024 was $353000.0, a N/A change from a year earlier, with the FY2016 full-year figure at $4000.0, down 96.83% from the prior year.
Total Debt was $353000.0 for Q4 2024 at VivoSim Labs, up from $8000.0 in the prior quarter.
The five-year high for Total Debt was $353000.0 in Q4 2024, with the low at $353000.0 in Q4 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Iqvia Holdings	44.72 Bn	42.64 Bn	1.44 Bn	16.00 Bn
2	Medpace Holdings	17.37 Bn	16.87 Bn	201.64 Mn	-
3	Icon	13.65 Bn	12.72 Bn	479.29 Mn	3.39 Bn
4	Charles River Laboratories International	13.13 Bn	12.94 Bn	452.07 Mn	2.62 Bn
5	Fortrea Holdings	1.89 Bn	1.72 Bn	139.20 Mn	1.05 Bn
6	Evotec SE	574.75 Mn	148.87 Mn	-	553.13 Mn
7	Ginkgo Bioworks Holdings	439.63 Mn	355.09 Mn	18.44 Mn	-
8	Champions Oncology	69.43 Mn	65.03 Mn	7.70 Mn	-
9	MindWalk Holdings	51.76 Mn	46.29 Mn	1.61 Mn	-
10	VivoSim Labs	1.37 Mn	1.37 Mn	-	-

Historic Data

Download Data